vs
BGSF, INC.（BGSF）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是BGSF, INC.的1.6倍（$35.5M vs $22.0M），BGSF, INC.净利率更高（-5.3% vs -304.2%，领先299.0%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -9.4%），BGSF, INC.自由现金流更多（$1.7M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -5.3%）
BGSF Inc.是一家总部位于美国的领先人力资源解决方案提供商，提供定制化人员派遣、人才招聘和全流程劳动力管理服务，覆盖信息技术、医疗健康、专业行政、轻工业、创意产业等核心领域，服务北美各规模的企业客户。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
BGSF vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.6倍
$22.0M
营收增速更快
RXRX
高出691.1%
-9.4%
净利率更高
BGSF
高出299.0%
-304.2%
自由现金流更多
BGSF
多$49.0M
$-47.3M
两年增速更快
RXRX
近两年复合增速
-5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $22.0M | $35.5M |
| 净利润 | $-1.2M | $-108.1M |
| 毛利率 | 35.0% | 59.8% |
| 营业利润率 | -17.6% | -304.8% |
| 净利率 | -5.3% | -304.2% |
| 营收同比 | -9.4% | 681.7% |
| 净利润同比 | -18.2% | 39.6% |
| 每股收益（稀释后） | $-0.12 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BGSFRXRX
| Q4 25 | $22.0M | $35.5M | ||
| Q3 25 | $26.9M | $5.2M | ||
| Q2 25 | $23.5M | $19.2M | ||
| Q1 25 | $20.9M | $14.7M | ||
| Q4 24 | $24.3M | $4.5M | ||
| Q3 24 | $29.8M | $26.1M | ||
| Q2 24 | $25.7M | $14.4M | ||
| Q1 24 | $24.5M | $13.8M |
净利润BGSFRXRX
| Q4 25 | $-1.2M | $-108.1M | ||
| Q3 25 | $-5.8M | $-162.3M | ||
| Q2 25 | $-3.7M | $-171.9M | ||
| Q1 25 | $-722.0K | $-202.5M | ||
| Q4 24 | $-981.0K | $-178.9M | ||
| Q3 24 | $-804.0K | $-95.8M | ||
| Q2 24 | $-761.0K | $-97.5M | ||
| Q1 24 | $-792.0K | $-91.4M |
毛利率BGSFRXRX
| Q4 25 | 35.0% | 59.8% | ||
| Q3 25 | 35.9% | -183.8% | ||
| Q2 25 | 35.8% | -4.9% | ||
| Q1 25 | 36.2% | -48.0% | ||
| Q4 24 | 35.9% | -181.4% | ||
| Q3 24 | 35.9% | 53.7% | ||
| Q2 24 | 37.3% | 36.2% | ||
| Q1 24 | 38.1% | 19.1% |
营业利润率BGSFRXRX
| Q4 25 | -17.6% | -304.8% | ||
| Q3 25 | -3.5% | -3327.6% | ||
| Q2 25 | -18.8% | -916.8% | ||
| Q1 25 | 1.6% | -1297.9% | ||
| Q4 24 | -15.7% | -4042.4% | ||
| Q3 24 | -3.4% | -377.1% | ||
| Q2 24 | -5.7% | -697.4% | ||
| Q1 24 | 1.7% | -698.4% |
净利率BGSFRXRX
| Q4 25 | -5.3% | -304.2% | ||
| Q3 25 | -21.6% | -3135.3% | ||
| Q2 25 | -15.9% | -894.2% | ||
| Q1 25 | -3.5% | -1373.3% | ||
| Q4 24 | -4.0% | -3935.5% | ||
| Q3 24 | -2.7% | -367.5% | ||
| Q2 24 | -3.0% | -676.6% | ||
| Q1 24 | -3.2% | -662.4% |
每股收益（稀释后）BGSFRXRX
| Q4 25 | $-0.12 | $-0.17 | ||
| Q3 25 | $-0.52 | $-0.36 | ||
| Q2 25 | $-0.34 | $-0.41 | ||
| Q1 25 | $-0.06 | $-0.50 | ||
| Q4 24 | — | $-0.56 | ||
| Q3 24 | $-0.07 | $-0.34 | ||
| Q2 24 | $-0.07 | $-0.40 | ||
| Q1 24 | — | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $48.1M | $1.1B |
| 总资产 | $57.8M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资BGSFRXRX
| Q4 25 | — | $743.3M | ||
| Q3 25 | $41.2M | $659.8M | ||
| Q2 25 | $2.8M | $525.1M | ||
| Q1 25 | $2.0M | $500.5M | ||
| Q4 24 | $32.0K | $594.4M | ||
| Q3 24 | $262 | $427.6M | ||
| Q2 24 | $226 | $474.3M | ||
| Q1 24 | $50 | $296.3M |
总债务BGSFRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益BGSFRXRX
| Q4 25 | $48.1M | $1.1B | ||
| Q3 25 | $50.7M | $1.0B | ||
| Q2 25 | $78.3M | $919.1M | ||
| Q1 25 | $81.8M | $933.9M | ||
| Q4 24 | $82.3M | $1.0B | ||
| Q3 24 | $82.9M | $524.6M | ||
| Q2 24 | $83.2M | $584.4M | ||
| Q1 24 | $83.6M | $401.2M |
总资产BGSFRXRX
| Q4 25 | $57.8M | $1.5B | ||
| Q3 25 | $83.6M | $1.4B | ||
| Q2 25 | $149.7M | $1.3B | ||
| Q1 25 | $152.3M | $1.3B | ||
| Q4 24 | $150.1M | $1.4B | ||
| Q3 24 | $157.3K | $726.5M | ||
| Q2 24 | $159.8K | $775.9M | ||
| Q1 24 | $170.6K | $557.8M |
负债/权益比BGSFRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.7M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $1.7M | $-47.3M |
| 自由现金流率自由现金流/营收 | 7.6% | -133.1% |
| 资本支出强度资本支出/营收 | 0.1% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-16.0K | $-378.3M |
8季度趋势，按日历期对齐
经营现金流BGSFRXRX
| Q4 25 | $1.7M | $-46.1M | ||
| Q3 25 | $-4.8M | $-117.4M | ||
| Q2 25 | $2.2M | $-76.4M | ||
| Q1 25 | $1.1M | $-132.0M | ||
| Q4 24 | $3.2M | $-115.4M | ||
| Q3 24 | $6.5M | $-59.2M | ||
| Q2 24 | $7.3M | $-82.2M | ||
| Q1 24 | $7.4M | $-102.3M |
自由现金流BGSFRXRX
| Q4 25 | $1.7M | $-47.3M | ||
| Q3 25 | $-4.9M | $-117.6M | ||
| Q2 25 | $2.1M | $-79.6M | ||
| Q1 25 | $1.0M | $-133.8M | ||
| Q4 24 | $2.5M | $-116.7M | ||
| Q3 24 | $6.5M | $-63.8M | ||
| Q2 24 | $7.3M | $-83.4M | ||
| Q1 24 | $6.9M | $-109.0M |
自由现金流率BGSFRXRX
| Q4 25 | 7.6% | -133.1% | ||
| Q3 25 | -18.1% | -2272.5% | ||
| Q2 25 | 9.1% | -413.9% | ||
| Q1 25 | 5.0% | -907.4% | ||
| Q4 24 | 10.2% | -2567.7% | ||
| Q3 24 | 21.7% | -244.6% | ||
| Q2 24 | 28.5% | -578.5% | ||
| Q1 24 | 28.1% | -789.9% |
资本支出强度BGSFRXRX
| Q4 25 | 0.1% | 3.5% | ||
| Q3 25 | 0.4% | 4.7% | ||
| Q2 25 | 0.0% | 16.4% | ||
| Q1 25 | 0.1% | 12.4% | ||
| Q4 24 | 3.0% | 28.6% | ||
| Q3 24 | 0.0% | 17.5% | ||
| Q2 24 | 0.0% | 8.2% | ||
| Q1 24 | 2.0% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BGSF
| Contract Field Talent | $21.4M | 97% |
| Other | $595.0K | 3% |
RXRX
暂无分部数据
